Study (year) Country Types Sample size ( Male (%) Age (y) Surgical methods Number of patients (DM/non-DM) Recoded parameters Adams et al. (2013) [14 ] USA Cohort 40 491 43% in DM and 36% in non-DM 68 in DM and 68 in non-DM TKA 7567/32924 Cardiac disease, kidney disease, DVT, revision, deep infection Amusat et al. (2014) [15 ] Australia Cohort 405 45% in DM and 37% in non-DM 67 in DM and 68 in non-DM TKA 60/345 Kidney disease, Bolognesi et al. (2008) [5 ] USA Cohort 742236 39 67 THA and TKA 63461/678775 Mortality, DVT Choong et al. (2007) [16 ] Australia Case-control 819 46 71 THA 87/732 Deep infection Chun et al. (2014) [17 ] Korea Case-control 413 61% in DM and 58% in non-DM 56 in DM and 51 in non-DM THA 41/372 Superficial infection Clement et al. (2013) [18 ] France Cohort 2389 44.4% in DM and 42.2% in non-DM 70.1 in DM and 70.4 in non-DM TKA 275/2114 HTN, cardiac disease Cordero-Ampuero et al. (2010) [19 ] Spain Case-control 124 NP NP THA 17/107 Superficial infection Duensing et al. (2019) [20 ] USA Cohort 75478 44.2% in DM and 40.7% in non-DM 65.6 in DM and 64.7 in non-DM TKA and THA 19854/55624 Deep infection Falcao et al. (2016) [21 ] USA Cohort 83 25% in DM and 37.3% in non-DM 72.8 in DM and 64.3 in non-DM THA 24/59 Deep infection Iorio et al. (2012) [22 ] USA Cohort 4008 NR NR TKA and THA 331/3677 Superficial infection Jämsen et al. (2012) [23 ] Finland Cohort 7181 36 70.6 TKA and THA 874/6307 Deep infection Lovecchio et al. (2014) [24 ] USA Cohort 43299 42% in DM and 38.6% in non-DM 66 in DM and 68 in non-DM TKA and THA 6725/36574 HTN, cardiac disease Maradit Kremers et al. (2017) [25 ] USA Cohort 16085 45.8 66 TKA and THA 2911/13147 Deep infection Martinez-Huedo et al. (2013) [27 ] Spain Cohort 373131 33.3% in DM and 33.8% in non-DM 71 in DM and 70% in non-DM TKA and THA 40519/332612 Mortality, Martínez-Huedo et al. (2017) [26 ] Spain Cohort 74834 37.2 71.5 TKA and THA 37417/37417 Mortality, DVT Meding et al. (2003) [28 ] USA Cohort 3519 48% in DM and 40% in non-DM 70 in DM and 70 in non-DM TKA 329/4891 DVT, deep infection Moon et al. (2008) [29 ] Korea Cohort 444 10.3% in DM and 10.3% in non-DM 67.6 in DM and 67.4 in non-DM TKA 222/222 DVT, superficial infection Namba et al. (2013) [30 ] USA Case-control 56216 37 67.4 TKA 14432/41784 Deep infection Suzuki et al. (2011) [31 ] Japan Case-control 2022 12.5 72 TKA 276/1746 Deep infection Teo et al. (2018) [32 ] Singapore Cohort 905 22% in DM and 21.4% in non-DM 67.7 in DM and 65.7 in non-DM TKA 123/782 HTN, cardiac disease, kidney disease, deep infection Wang et al. (2013) [33 ] China Cohort 245 32.1% in DM and 28.6% in non-DM 67 in DM and 67.1 in non-DM TKA 53/192 DVT, HTN, cardiac disease Webb et al. (2017) [34 ] USA Cohort 114102 40.8% in DM and 36.6% in non-DM NP TKA 20248/93854 Cardiac disease, cerebrovascular disease, kidney disease Zhao et al. (2014) [35 ] China Cohort 358 28.6% in DM and 34.7% in non-DM 68.09 in DM and 68.17 in non-DM TKA 70/288 HTN, DVT
